{
  "id": "5e49c5336d0a277941000011",
  "type": "yesno",
  "question": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
  "ideal_answer": "No, LY6K overexpression is associated with poor prognosis for patients with NSCLC.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18089789"
  ],
  "snippets": [
    {
      "text": "Gene expression profile analyses of non-small cell lung carcinomas (NSCLC) and esophageal squamous cell carcinomas (ESCC) revealed that lymphocyte antigen 6 complex locus K (LY6K) was specifically expressed in testis and transactivated in a majority of NSCLCs and ESCCs. Immunohistochemical staining using 406 NSCLC and 265 ESCC specimens confirmed that LY6K overexpression was associated with poor prognosis for patients with NSCLC (P = 0.0003), as well as ESCC (P = 0.0278), and multivariate analysis confirmed its independent prognostic value for NSCLC (P = 0.0035). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18089789",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Immunohistochemical staining using 406 NSCLC and 265 ESCC specimens confirmed that LY6K overexpression was associated with poor prognosis for patients with NSCLC (P = 0.0003), as well as ESCC (P = 0.0278), and multivariate analysis confirmed its independent prognostic value for NSCLC (P = 0.0035).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18089789",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Immunohistochemical staining using 406 NSCLC and 265 ESCC specimens confirmed that LY6K overexpression was associated with poor prognosis for patients with NSCLC (P = 0.0003), as well as ESCC (P = 0.0278), and multivariate analysis confirmed its independent prognostic value for NSCLC (P = 0.0035).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18089789",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}